Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mars Stone

Showing results (161-170 of 169) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 169 results.
Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.
Nature Microbiology|January 23, 2020
Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
Nature Microbiology|January 15, 2020
Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
Journal of Virology|October 6, 2017
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in HumansAlba Grifoni, John Pham, John Sidney, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 17

Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Nature Communications|January 23, 2021
SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaquesYashavanth Shaan Lakshmanappa, Sonny R Elizaldi, Jamin W Roh, et al.
Nature Microbiology|January 23, 2020
Author Correction: Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
Nature Microbiology|January 15, 2020
Metagenomic sequencing with spiked primer enrichment for viral diagnostics and genomic surveillanceXianding Deng, Asmeeta Achari, Scot Federman, et al.
Journal of Virology|October 6, 2017
Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in HumansAlba Grifoni, John Pham, John Sidney, et al.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood from the San Francisco Bay AreaDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Science Advances|July 31, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Pageof 17